Bruderman Asset Management, LLC Novartis Ag Transaction History

Bruderman Asset Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 13, 2020	SELL	$84.35 - $95.37 $269,245 - $304,421	-3,192 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$85.54 - $94.26 $11,462 - $12,630	134 Added 4.38%	3,192 $282,000
Q2 2019 Aug 12, 2019	SELL	$75.4 - $92.8 $81,658 - $100,502	-1,083 Reduced 26.15%	3,058 $279,000
Q1 2019 May 14, 2019	SELL	$75.32 - $86.15 $27,717 - $31,703	-368 Reduced 8.16%	4,141 $398,000
Q4 2018 Feb 11, 2019	BUY	$73.66 - $82.02 $69,977 - $77,919	950 Added 26.69%	4,509 $387,000
Q3 2018 Nov 09, 2018	SELL	$66.94 - $77.43 $133,746 - $154,705	-1,998 Reduced 35.95%	3,559 $307,000
Q2 2018 Aug 15, 2018	SELL	$64.91 - $73.36 $199,987 - $226,022	-3,081 Reduced 35.67%	5,557 $420,000
Q1 2018 May 10, 2018	SELL	$70.39 - $84.15 $19,005 - $22,720	-270 Reduced 3.03%	8,638 $698,000
Q4 2017 Feb 06, 2018	SELL	$72.33 - $77.64 $96,922 - $104,037	-1,340 Reduced 13.08%	8,908 $748,000
Q3 2017 Nov 13, 2017	BUY	$74.14 - $77.27 $759,786 - $791,862	10,248	10,248 $880,000

1,435

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Bruderman Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bruderman Asset Management, LLC with notifications on news.